Canopy Growth (CGC) EBT Margin Growth (1y) (2020 - 2025)
Canopy Growth (CGC) EBT Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,258.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 132.00 |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,048.00 |
| Sep 30, 2025 | 17,053.00 |
| Jun 30, 2025 | 9,186.00 |
| Dec 31, 2024 | 14,974.00 |
| Sep 30, 2024 | 442.00 |
| Jun 30, 2024 | -14,244.00 |
| Mar 31, 2024 | 31,075.00 |
| Dec 31, 2023 | -1,160.00 |
| Sep 30, 2023 | 3,197.00 |
| Jun 30, 2023 | 174,833.00 |
| Mar 31, 2023 | -67,154.00 |
| Dec 31, 2022 | -19,430.00 |
| Sep 30, 2022 | -19,919.00 |
| Jun 30, 2022 | -204,797.00 |
| Mar 31, 2022 | 51,470.00 |
| Dec 31, 2021 | 478,671.00 |
| Sep 30, 2021 | 5,610.00 |
| Jun 30, 2021 | 39,873.00 |
| Mar 31, 2021 | 95,746.00 |
| Dec 31, 2020 | -475,057.00 |